Skip to main content
. Author manuscript; available in PMC: 2011 Oct 25.
Published in final edited form as: Carbohydr Res. 2010 Apr 24;345(10):1371–1376. doi: 10.1016/j.carres.2010.04.015

Figure 3.

Figure 3

Relative lysosomal β-glucosidase and β-N-acetylhexosaminidase activities in Gaucher fibroblast (N370S/N370S) cell-line treated with ABX, 10 and 11. Lysosomal enzyme activities of β-glucosidase (A) and β-N-acetylhexosaminidase (B) for each dose of ABX, 10 or 11 were normalized to activities found in lysates from vehicle (0.1% DMSO) treated patient cells. All treatments were performed in triplicate. Treatment groups showing a statistically significant increase relative to DMSO treated cells are marked with an asterisk (p <0.05). Dashed line demarcates relative activity levels greater or less than 1.